Prudent Man Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
14,028
+2,211
| +19% | +$183K | 0.37% | 66 |
|
|
2025
Q1 | $958K | Hold |
11,817
| – | – | 0.35% | 67 |
|
|
2024
Q4 | $1.06M | Sell |
11,817
-1,338
| -10% | -$121K | 0.39% | 57 |
|
|
2024
Q3 | $1.3M | Buy |
13,155
+1,771
| +16% | +$175K | 0.43% | 48 |
|
|
2024
Q2 | $1.06M | Buy |
11,384
+1,139
| +11% | +$106K | 0.37% | 60 |
|
|
2024
Q1 | $972K | Sell |
10,245
-476
| -4% | -$45.2K | 0.36% | 64 |
|
|
2023
Q4 | $957K | Sell |
10,721
-1,203
| -10% | -$107K | 0.36% | 60 |
|
|
2023
Q3 | $871K | Sell |
11,924
-281
| -2% | -$20.5K | 0.35% | 66 |
|
|
2023
Q2 | $1.02M | Hold |
12,205
| – | – | 0.38% | 55 |
|
|
2023
Q1 | $930K | Hold |
12,205
| – | – | 0.36% | 58 |
|
|
2022
Q4 | $1.01M | Buy |
12,205
+1,503
| +14% | +$125K | 0.41% | 55 |
|
|
2022
Q3 | $849K | Buy |
10,702
+278
| +3% | +$22.1K | 0.4% | 50 |
|
|
2022
Q2 | $774K | Sell |
10,424
-706
| -6% | -$52.4K | 0.36% | 52 |
|
|
2022
Q1 | $1M | Sell |
11,130
-433
| -4% | -$38.9K | 0.41% | 49 |
|
|
2021
Q4 | $1.3M | Sell |
11,563
-2,028
| -15% | -$227K | 0.49% | 40 |
|
|
2021
Q3 | $1.71M | Buy |
13,591
+1,907
| +16% | +$240K | 0.65% | 27 |
|
|
2021
Q2 | $1.58M | Buy |
11,684
+19
| +0.2% | +$2.57K | 0.61% | 30 |
|
|
2021
Q1 | $1.58M | Buy |
11,665
+65
| +0.6% | +$8.82K | 0.66% | 27 |
|
|
2020
Q4 | $1.63M | Buy |
11,600
+3,204
| +38% | +$451K | 0.68% | 21 |
|
|
2020
Q3 | $936K | Sell |
8,396
-59
| -0.7% | -$6.58K | 0.5% | 42 |
|
|
2020
Q2 | $947K | Buy |
+8,455
| New | +$947K | 0.84% | 29 |
|